Abiomed EV/Sales
What is the EV/Sales of Abiomed?
The EV/Sales of Abiomed Inc. is 15.23
What is the definition of EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales of companies in the Health Care sector on NASDAQ compared to Abiomed
What does Abiomed do?
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Companies with ev/sales similar to Abiomed
- JPMorgan Claverhouse Investment Trust Plc has EV/Sales of 15.18
- ICG Enterprise Trust Plc has EV/Sales of 15.18
- PNE AG has EV/Sales of 15.19
- Invesco Senior Income Trust has EV/Sales of 15.19
- Matador Mining has EV/Sales of 15.21
- Nuveen Preferred & Income Opportunities Fund has EV/Sales of 15.21
- Abiomed has EV/Sales of 15.23
- Wheaton Precious Metals has EV/Sales of 15.24
- CK Infrastructure has EV/Sales of 15.24
- Oriental Payment has EV/Sales of 15.25
- MERLIN Properties SOCIMI, S.A has EV/Sales of 15.26
- Nuveen Credit Strategies Income Fund has EV/Sales of 15.27
- Whitefield has EV/Sales of 15.29